Your account is not claimed yet. You can sign up with ORCID to claim your account.

Ibrahim Halil Sahin

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 9

Top Venues

JCO oncology practice

The oncologist

Future oncology (London, England)

British journal of cancer

H Lee Moffitt Cancer Center and Research Center Inc

This page only lists publications with an associated author ORCID identifier.

Affiliation History

H Lee Moffitt Cancer Center and Research Center Inc Aug 1o 2020

United States

Assistant Professor of Medicine :: Gastrointestinal Oncology

Publications

Ibrahim Halil Sahin, Janie Y Zhang, Turcin Saridogan, Vikram Gorantla, John Rhree, Monica Malhotra, Roby Thomas, Dennis J Hsu, Anwaar Saeed
Neoadjuvant Immune Checkpoint Inhibitor Therapy for Patients With Microsatellite Instability-High Colorectal Cancer: Shedding Light on the Future. JCO oncology practice (2023)
Charan Thej Reddy Vegivinti, Cyndi Gonzales Gomez, Masood Syed, Morgan Ferrell, Svea Cheng, Aatur Singhi, Anwaar Saeed, Ibrahim Halil Sahin
The role of immune checkpoint inhibitors for patients with advanced stage microsatellite stable colorectal cancer and high tumor mutation burden: quantity or quality? Expert opinion on biological therapy (2023)
Deniz Can Guven, Enes Erul, Taha Koray Sahin, Omer Dizdar, Suayib Yalcin, Ibrahim Halil Sahin
The benefit of immunotherapy in patients with hepatocellular carcinoma: a systematic review and meta-analysis. Future oncology (London, England) (2022)
Canan Karan, Elaine S Tan, Humaira Sarfraz, Todd C Knepper, Christine M Walko, Seth Felder, Richard D Kim, Ibrahim Halil Sahin
Human Epidermal Growth Factor Receptor 2-Targeting Approaches for Colorectal Cancer: Clinical Implications of Novel Treatments and Future Therapeutic Avenues. JCO oncology practice 18 (8) (2022)
Elaine Tan, Junmin Whiting, Hao Xie, Iman Imanirad, Estrella Carballido, Seth Felder, Jessica Frakes, Quanxing Mo, Christine Walko, Jennifer B Permuth, Katelyn Sommerer, Richard D Kim, Daniel A Anaya, Jason B Fleming, Ibrahim Halil Sahin
BRAF Mutations Are Associated with Poor Survival Outcomes in Advanced-stage Mismatch Repair-deficient/Microsatellite High Colorectal Cancer. The oncologist 27 (3) (2022)
Ibrahim Halil Sahin, Jim Klostergaard
BRAF Mutations as Actionable Targets: A Paradigm Shift in the Management of Colorectal Cancer and Novel Avenues. JCO oncology practice 17 (12) (2021)
Ibrahim Halil Sahin, Subir Goyal, Yoanna Pumpalova, Mohamad B Sonbol, Satya Das, Sigurdis Haraldsdottir, Daniel Ahn, Kristen K Ciombor, Zhengjia Chen, Amber Draper, Jordan Berlin, Tanios Bekaii-Saab, Gregory B Lesinski, Bassel F El-Rayes, Christina Wu
Mismatch Repair (MMR) Gene Alteration and BRAF V600E Mutation Are Potential Predictive Biomarkers of Immune Checkpoint Inhibitors in MMR-Deficient Colorectal Cancer. The oncologist 26 (8) (2021)
Ibrahim Halil Sahin, Mehmet Akce, Olatunji Alese, Walid Shaib, Gregory B Lesinski, Bassel El-Rayes, Christina Wu
Immune checkpoint inhibitors for the treatment of MSI-H/MMR-D colorectal cancer and a perspective on resistance mechanisms. British journal of cancer 121 (10) (2019)
Irem Guler, Gokce Askan, Jim Klostergaard, Ibrahim Halil Sahin
Precision medicine for metastatic colorectal cancer: an evolving era. Expert review of gastroenterology & hepatology 13 (10) (2019)

Ibrahim Halil Sahin.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ibrahim Halil Sahin